Search Results - "Tuy, Kaysaw"
-
1
Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance
Published in Redox biology (01-08-2021)“…Controlling reactive oxygen species (ROS) at sustainable levels can drive multiple facets of tumor biology, including within the cancer stem cell (CSC)…”
Get full text
Journal Article -
2
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
Published in Cell adhesion & migration (01-01-2021)“…The multifaceted roles of metabolism in invasion have been investigated across many cancers. The brain tumor glioblastoma (GBM) is a highly invasive and…”
Get full text
Journal Article -
3
α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth
Published in JCI insight (08-11-2022)“…One of the least-investigated areas of brain pathology research is glycosylation, which is a critical regulator of cell surface protein structure and function…”
Get full text
Journal Article -
4
EXTH-12. CYTOCHROME C OXIDASE SUBUNIT 4 ISOFORM 1 MEDIATES ONCOLYTIC HERPES SIMPLEX VIRUS-1 EFFICACY IN HIGH-GRADE GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)Get full text
Journal Article -
5
DDRE-22. DISRUPTING REDOX BALANCE VIA THE TETRAHYDROBIOPTERIN PATHWAY IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Aberrant redox statuses are observed in glioblastoma (GBM), and we previously identified GTP cyclohydrolase I (GCH1) to be a redox regulator upregulated in…”
Get full text
Journal Article -
6
STEM-08. ST6Gal1-MEDIATED SILALYLATION IS CRITICAL FOR GLIOBLASTOMA GROWTH
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Although altered cell surface glycosylation was one of the earliest modifications observed in neoplastic progression, this facet of cancer cell biology has…”
Get full text
Journal Article -
7
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma
Published in Cancers (15-08-2024)“…Glioblastoma (GBM) is an immunologically cold tumor, but several immunotherapy-based strategies show promise, including the administration of ex vivo expanded…”
Get full text
Journal Article